Novel CREB3L3 Nonsense Mutation in a Family With Dominant Hypertriglyceridemia
暂无分享,去创建一个
C. Barbagallo | D. Noto | R. Spina | M. Averna | A. Giammanco | A. Cefalù | A. Ganci | V. Valenti | V. Ingrassia | Maria D. Panno
[1] J. Borén,et al. The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. , 2014, The lancet. Diabetes & endocrinology.
[2] B. Nordestgaard,et al. Loss-of-function mutations in APOC3 and risk of ischemic vascular disease. , 2014, The New England journal of medicine.
[3] Meghan C Towne,et al. A compound heterozygous mutation in GPD1 causes hepatomegaly, steatohepatitis, and hypertriglyceridemia , 2014, European Journal of Human Genetics.
[4] R. Kaufman,et al. Endoplasmic reticulum‐tethered transcription factor cAMP responsive element‐binding protein, hepatocyte specific, regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress in mice , 2012, Hepatology.
[5] S. Yusuf,et al. Excess of Rare Variants in Non–Genome-Wide Association Study Candidate Genes in Patients With Hypertriglyceridemia , 2012, Circulation. Cardiovascular genetics.
[6] R. Hegele,et al. Transient infantile hypertriglyceridemia, fatty liver, and hepatic fibrosis caused by mutated GPD1, encoding glycerol-3-phosphate dehydrogenase 1. , 2012, American journal of human genetics.
[7] R. Fresa,et al. Two novel rare variants of APOA5 gene found in subjects with severe hypertriglyceridemia. , 2011, Clinica chimica acta; international journal of clinical chemistry.
[8] R. Hegele,et al. Genetic bases of hypertriglyceridemic phenotypes , 2011, Current opinion in lipidology.
[9] R. Hegele,et al. The transcription factor cyclic AMP–responsive element–binding protein H regulates triglyceride metabolism , 2011, Nature Medicine.
[10] S. Kathiresan,et al. Genetic determinants of plasma triglycerides , 2011, Journal of Lipid Research.
[11] Young-sil Yoon,et al. Regulation of hepatic gluconeogenesis by an ER-bound transcription factor, CREBH. , 2010, Cell metabolism.
[12] H. Shimano,et al. The liver-enriched transcription factor CREBH is nutritionally regulated and activated by fatty acids and PPARalpha. , 2010, Biochemical and biophysical research communications.
[13] M. Taskinen,et al. Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia. , 2009, The Journal of clinical endocrinology and metabolism.
[14] R. Kaufman,et al. ER Stress Controls Iron Metabolism Through Induction of Hepcidin , 2009, Science.
[15] J. Danesh,et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. , 2007, JAMA.
[16] R. Hegele,et al. Hypertriglyceridemia: its etiology, effects and treatment , 2007, Canadian Medical Association Journal.
[17] Randal J. Kaufman,et al. Endoplasmic Reticulum Stress Activates Cleavage of CREBH to Induce a Systemic Inflammatory Response , 2006, Cell.
[18] L. Pennacchio,et al. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. , 2005, The Journal of biological chemistry.
[19] A. Tanigami,et al. CREB-H: a novel mammalian transcription factor belonging to the CREB/ATF family and functioning via the box-B element with a liver-specific expression. , 2001, Nucleic acids research.
[20] L. Havekes,et al. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[21] R E Rose,et al. A cyclic AMP-responsive element-binding transcriptional activator in Drosophila melanogaster, dCREB-A, is a member of the leucine zipper family , 1992, Molecular and cellular biology.
[22] T. Maniatis,et al. A Drosophila CREB/ATF transcriptional activator binds to both fat body- and liver-specific regulatory elements. , 1992, Genes & development.
[23] S. Kliewer,et al. Fibroblast growth factor 21: from pharmacology to physiology. , 2010, The American journal of clinical nutrition.